Piramal Pharma sets analyst meeting for November 28

Piramal Pharma Limited announced an upcoming analyst and institutional investor meeting for November 28, 2025. The meeting, which will be held in Mumbai, is scheduled with Citi India Pharma & Healthcare Tour 2025.

The event is designated as a group and one-on-one in-person meeting. This intimation is made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Piramal Pharma also noted that the scheduled dates are subject to change, with potential alterations due to exigencies on the part of either the investors or the company. The announcement was signed by Tanya Sanish, company secretary, on November 19, 2025.